Pharmafile Logo
Pharmafocus logo
Advanced Search
novonordisk

Novo Nordisk to cut 2% of its entire workforce

September 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Denmark, Novo Nordisk, diabetes, insulin, job cuts, job losses

Novo Nordisk, headquartered in Bagsvaerd, Denmark, has taken the decision to lose 1,000 of its workforce from a total global …

News
eylea-product-box-md

NICE approves Bayer’s Eylea for NHS use

September 28, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Eylea, NICE

Bayer has announced that its Eylea (aflibercept) drug has received a final recommendation from NICE for the treatment of visual …

News
laboratory

GW Pharma releases positive data on cannabidiol-based Phase III trial

September 28, 2016
Research and Development Epidiolex, GW Pharmaceuticals, Marijuana, Medical marijuana, cannabis

GW Pharmaceuticals’ Epidiolex is designed to treat seizures in a rare form of epilepsy called Lennox-Gaustaut Syndrome. GW pharmaceuticals published …

News
malaysia-645561_960_720

Malaysian pharmaceutical market set to grow to $3.6 billion by 2020

September 28, 2016
Research and Development

The report, by GlobalData, states that the primary reasons behind this growth are linked to medical tourism, a lack of …

News
abbvie_0

AbbVie and Eisai celebrate approval of new Humira indication

September 28, 2016
Research and Development, Sales and Marketing AbbVie, Eisai, Humira

AbbVie and Eisai have announced the Japanese approval of a new indication for the former’s anti-TNF-α monoclonal antibody formulation Humira …

News
mark_zuckerberg_-_south_by_southwest_2008

Zuckerberg appoints AstraZeneca’s Cornelia Bargmann

September 28, 2016
Research and Development AstraZeneca, Facebook, Mark Zuckerberg, Priscilla Chan

Zuckerberg and Chan have committed $3 billion of their own money to setting up the health initiative that has an …

News
china-pharmaceutical-industry

80% of Chinese clinical trials’ data fabricated

September 28, 2016
Manufacturing and Production, Research and Development China, Fabrication, corruption, report

The government review of clinical trial practise involved 1,622 programs of new pharmaceutical drugs waiting upon government approval to begin …

News
gilead-sciences

Provisional NICE recommendation for Gilead’s Hepatitis C treatment

September 28, 2016
Research and Development, Sales and Marketing Epclusa, NICE, hepatitis C

NICE has issued provisional guidance recommending the use of Gilead Sciences’ Epclusa (sofosbuvir 400 mg/velpatasvir 100 mg) for the treatment …

News

Merck elects Isabel De Paoli as CSO

September 27, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CSO, Merck, appointment

German pharma firm Merck has appointed Isabel De Paoli to the position of chief science officer in addition to her …

Appointment
amgen_hq

Amgen’s Kyprolis disappoints in Phase III trial

September 27, 2016
Manufacturing and Production, Research and Development Amgen, Kyprolis, phase III

Amgen was relying on the results of the trial to justify its $10.4 billion purchase of Onyx Pharmaceuticals, acquiring Kyprolis …

News
cancer-389921_960_720

Kite Pharma flying high after promising Car-T trial

September 27, 2016
Manufacturing and Production, Research and Development Cancer, Cart-T, kite pharma

Cart-T cell drugs are made by genetically altering patients’ T-cells to add a component of antibodies that make them better …

News
heather_bresch_2

Price-hiked EpiPen profits 66% higher than Mylan CEO claimed

September 27, 2016
Business Services, Manufacturing and Production, Sales and Marketing Heather Bresch, Mylan, epipen

In the latest development in the Mylan EpiPen scandal, it has been discovered that CEO Heather Bresch lied to US …

News

Sanofi secures $43 million government funding for zika vaccine development

September 27, 2016
Manufacturing and Production, Research and Development BARDA, Sanofi, Zika

The US Department of Health and Human Services approved $43.18 million to fund Sanofi’s development of a zika vaccine, the …

News
jj_2johnson_and_johnson

Johnson & Johnson’s Stelara receives FDA approval

September 27, 2016
Manufacturing and Production, Research and Development Janssen Biotech, Johnson & Johnson, Stelara

The drug is approved for use to treat the skin condition scaly plaque psoriasis and a type of arthritis associated …

News
biogen_austria_238

Biogen closes in on bringing muscular atrophy preventing drug to market

September 26, 2016
Manufacturing and Production, Research and Development Biogen, EMA, FDA, Nusinersen

Biogen has applied for Priority Review, which, if granted, would shorten the review period necessary for nusinersen. They also plan …

News

CPHI Worldwide: PCI to Share Expertise in Serialization and Safe Handling of Potent Molecules

September 26, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPhI

Leading pharmaceutical provider PCI Pharma Services will bring its expertise to the stage at CPHI Worldwide (Barcelona, October 4-6 2016) …

News
Press release

Pfizer decides not to break up business

September 26, 2016
Sales and Marketing Ian Read, Pfizer, United States, america

In the intervening four years, Pfizer has conducted “extensive evaluation” into the possibility, with the company reorganising into two distinct …

News
australian-flag-map_zps69235009

Australian pharmaceutical market to grow to be worth $25 billion by 2020

September 26, 2016
Business Services, Sales and Marketing Australia, Australian Government

The Australian market, in 2016, is currently worth over $22.85 billion and is predicted to reach $25.2 billion by 2020, …

News
fda2outsideweb

Sanofi and Regeneron’s atopic dermatitis drug secures FDA priority review

September 26, 2016
Research and Development, Sales and Marketing

Regeneron and Sanofi have announced that the US Food and Drug Administration has granted priority review for the pair’s atopic …

News

Merck elects Isabel De Paoli as CSO

September 26, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, appointment

German pharma firm Merck has appointed Isabel De Paoli to the position of chief science officer in addition to her …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026